Validation of a digital identification tool for individuals at risk for hereditary cancer syndromes.
Leslie BucheitKatherine Johansen TaberKaylene ReadyPublished in: Hereditary cancer in clinical practice (2019)
The digital ID tool accurately matches NCCN criteria in one-to-one fashion to identify at-risk individuals for HCS and may be useful in clinical practice, specifically for BRCA-related HBOC and Lynch Syndrome.